SELECT * FROM `tbl_content` WHERE `c_type` = 'advertise' AND `c_status` = '1' AND `c_is_deleted` = '0' ORDER BY `c_order` desc LIMIT 3 Association of Biotechnology Led Enterprises

News

Lupin and AbbVie partner to develop hematological cancers drugs

Through this partnership, AbbVie gains exclusive global rights to develop and commercialize Lupin’s MALT1 inhibitors.

Dec 26, 2018

By : By Team ABLE

Quest Diagnostics completes sale of India diagnostics services business to Strand Life Sciences

Quest Diagnosticshas completed the sale of its India medical diagnostic service business to Strand Life Sciences.

Dec 26, 2018

By : By Team ABLE

USA UK Ireland scientist partner AMTZ to further biomaterials research

At a recently held event, AMTZ and KIHT brought the bio-materials community together and exchanged ideas on how the entire ecosystem can promote indigenous products researched at Indian institutions of merit.

Dec 26, 2018

By : By Team ABLE

China’s HitGen Bayer enter DNA-encoded library-basedresearch collaboration

“Our research and development (R&D) platforms are supplemented by what we call an ‘open innovation’ model,” said Axel Trautwein, Head of Small Molecules, Crop Science division of Bayer. “HitGen’s experience in DNA-encoded chemistry fits that model well, and we look forward to using their advanced technology platform to develop solutions that help farmers control existing crop threats and get ahead of emerging ones.”

Dec 21, 2018

By : By Team ABLE

Propanc Biopharma’s cancer treatment granted patent in India

“Building a robust patent portfolio has been a top priority in driving our drug development technology forward. Adding India to the growing list of countries where we have been granted patents reflects the strength of our growing IP portfolio for PRP,” said James Nathanielsz, Propanc’s Chief Executive Officer.

Dec 21, 2018

By : By Team ABLE

 

Archives